The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Loss-of-Function Mutations in the Cardiac Calcium Channel Underlie a New Clinical Entity Characterized by ST-Segment Elevation, Short QT Intervals, and Sudden Cardiac Death
Open accessAbstract
Background— Cardiac ion channelopathies are responsible for an ever-increasing number and diversity of familial cardiac arrhythmia syndromes. We describe a new clinical entity that consists of an ST-segment elevation in the right precordial ECG leads, a shorter-than-normal QT interval, and a history of sudden cardiac death. Methods and Results— Eighty-two consecutive probands with Brugada syndrome were screened for ion channel gene mutations with direct sequencing. Site-directed mutagenesis was performed, and CHO-K1 cells were cotransfected with cDNAs encoding wild-type or mutant CACNB2b (Ca vβ2b ), CACNA2D1 (Ca vα2δ1 ), and CACNA1C tagged with enhanced yellow fluorescent protein (Ca v 1.2). Whole-cell patch-clamp studies were performed after 48 to 72 hours. Three probands displaying ST-segment elevation and corrected QT intervals ≤360 ms had mutations in genes encoding the cardiac L-type calcium channel. Corrected QT ranged from 330 to 370 ms among probands and clinically affected family members. Rate adaptation of QT interval was reduced. Quinidine normalized the QT interval and prevented stimulation-induced ventricular tachycardia. Genetic and heterologous expression studies revealed loss-of-function missense mutations in CACNA1C (A39V and G490R) and CACNB2 (S481L) encoding the α 1 - and β 2b -subunits of the L-type calcium channel. Confocal microscopy revealed a defect in trafficking of A39V Ca v 1.2 channels but normal trafficking of channels containing G490R Ca v 1.2 or S481L Ca vβ2b -subunits. Conclusions— This is the first report of loss-of-function mutations in genes encoding the cardiac L-type calcium channel to be associated with a familial sudden cardiac death syndrome in which a Brugada syndrome phenotype is combined with shorter-than-normal QT intervals.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Short QT syndrome KCNH2 KCNQ1 KCNJ2 CACNA1C CACNB2b IKr IKs IK1 ICa ICa Up to 70% 853, 856-858”
From 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS (2016) · cites this paper as [853]
In the citing paper
“Brugada syndrome SCN5A GPDIL SCN1B CACNA1C CACNB2b others INa INa INa ICa ICa others 10-20% 851-855”
From 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS (2016) · cites this paper as [853]
In the citing paper
“AF prevalence ranges from 5% to 20% in patients with long QT syndrome or Brugada syndrome, and is up to 70% in short QT syndrome (Table 20).853,[856][857][858]”
From 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS (2016) · cites this paper as [853]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
CaV1.2 Calcium Channel Dysfunction Causes a Multisystem Disorder Including Arrhythmia and Autism
Splawski, I., Timothy, K. W., Sharpe, L. M., Decher, N., Kumar, P., Bloise, R., Napolitano, C., Schwartz, P. J., Joseph, R. M., Condouris, K., et al. (2004) · Cell · doi:10.1016/j.cell.2004.09.011 · Cited by 1,586 · cited 1×
“val; (3) the 3 mutations are not observed in ethnically matched healthy individuals; and (4) there is a clear genotype-phenotype”
BackgroundSelf-citationSudden death associated with short-QT syndrome linked to mutations in HERG
Brugada, R., Hong, K., Dumaine, R., Cordeiro, J., Gaita, F., Borggrefe, M., Menendez, T. M., Brugada, J., Pollevick, G. D., Wolpert, C., et al. (2004) · Circulation · doi:10.1161/01.cir.0000109482.92774.3a · Cited by 847
Research works printed but not linked: 31
- 10.1053/eupc.2001.0214 · DOI
- 10.1016/j.hrthm.2004.10.018 · DOI
- 10.1073/pnas.0502506102 · DOI · Paper page
- 10.1016/S0896-6273(00)80881-8 · DOI
- Gussak I Antzelevitch C Goodman D Bjerregaard P. Short QT interval: ECG phenomenon and clinical syndrome. In: Gussak I Antzelevitch C eds. Cardiac Repolarization: Bridging Basic and Clinical Sciences. Totowa NJ: Humana Press; 2003: 497–506. · DOI
- 10.1161/01.CIR.0000115205.70330.05 · DOI
- 10.1161/01.cir.0000130409.72142.fe · DOI
- 10.1161/01.res.0000162101.76263.8c · DOI
- 10.1038/32675 · DOI
- 10.1161/01.cir.0000034169.45752.4a · DOI
- 10.1161/01.cir.0000152479.54298.51 · DOI
- Rautaharju PM, Zhou SH, Wong S, Calhoun HP, Berenson GS, Prineas R, Davignon A. Sex differences in the evolution of the electrocardiographic QT interval with age. Can J Cardiol. 1992; 8: 690–695.
- 10.1016/j.hrthm.2004.07.010 · DOI
- 10.1016/j.cell.2005.08.004 · DOI · Paper page
- 10.1074/jbc.M412140200 · DOI
- 10.1016/S0014-5793(98)00425-6 · DOI
- 10.1016/j.hrthm.2004.03.061 · DOI
- 10.1016/j.jelectrocard.2005.06.005 · DOI
- 10.1046/j.1540-8167.2004.03341.x · DOI
- 10.1161/01.cir.0000143078.48699.0c · DOI
- 10.1016/S0735-1097(02)01852-1 · DOI
- 10.1046/j.1540-8167.2005.04470.x · DOI
- Borggrefe M. Atrial tachyarrhythmias in Brugada syndrome. In: Antzelevitch C Brugada P Brugada J Brugada R eds. The Brugada Syndrome: From Bench to Bedside. Oxford UK: Blackwell Futura; 2004: 178–183. · DOI
- 10.1093/eurheartj/ehl185 · DOI · Paper page
- 10.1016/j.jacc.2004.02.034 · DOI
- 10.1161/01.cir.0000143159.30585.90 · DOI
- 10.1002/humu.9144 · DOI
- 10.1016/0092-8674(95)90359-3 · DOI
- 10.1016/0092-8674(95)90358-5 · DOI
- 10.1038/ng0196-17 · DOI
- London B, Sanyal S, Michalec M, Pfahnl AE, Shang LL, Kerchner BS, Lagana S, Aleong RG, Mehdi H, Gutmann R, Weiss R, Dudley SC. A mutation in the glycerol-3-phosphate dehydrogenase 1-like gene (GPD1L) causes Brugada syndrome. Heart Rhythm. 2006; 3: S32. Abstract.
Cited by
Sorted by citations
Items 501–600 of 825
Biernacka, E., Osadnik, T., Bilińska, Z., Krawczyński, M., Latos-Bieleńska, A., Laczmanska, I., Miszczak-Knecht, M., Płoski, R., Ponińska, J., Prejbisz, A., et al. (2024) · Kardiologia polska · doi:10.33963/v.phj.100490 · Cited by 9
“In the case of phenotypes overlapping with BrS, mutations in L-type calcium channel-related genes may underlie the phenotype [63].”
BackgroundZhao, Z., Zang, X., Niu, K., Song, W., Wang, X., Mügge, A., Aweimer, A., Hamdani, N., Zhou, X., Zhao, Y., et al. (2024) · EBioMedicine · doi:10.1016/j.ebiom.2024.105108 · Cited by 11
“It has been reported that quinidine might be an effective drug for SQTS patients carrying calcium channel gene variants 29,58 El-Battrawy et al. illustrated that quinidine and amiodarone prolonged APD in a patient with SQTS overlapped with BrS carrying a variant (c.1439C > T/p. S480L) in CACNB2…”
BackgroundSystemic primary carnitine deficiency induces severe arrhythmia due to shortening of QT interval
Lodewyckx, P., Issa, J., Gaschignard, M., Lamireau, D., de Lonlay, P., Servais, A., Barth, M., Courapied, S., Morin, G., Benbrik, N., et al. (2023) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2023.107733 · Cited by 13
Theisen, B. W., Holtz, A., & Rajagopalan, V. (2023) · Cells · doi:10.3390/cells12192398 · Cited by 9
“Both the genes have a prevalence of 1–2% in BrS cases [16,171].”
Storlund, R. L., Rosen, D., & Trites, A. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.690029 · Cited by 9
Park, M.-H., Park, S.-I., Kim, J.-H., Yu, J., Lee, E. H., Seo, S., & Jo, S. (2019) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2019.110488 · Cited by 9
Circulating Circles Predict Postoperative Atrial Fibrillation
Reckman, Y. J., & Creemers, E. E. (2018) · Journal of the American Heart Association · doi:10.1161/jaha.117.008261 · Cited by 10
“Loss-of-function mutations in CACNA1C are associated with short QT and Brugada syndrome, both of which are clinically associated with AF.(18) It is known that CACNA1C is subject to extensive alternative splicing, and it is conceivable that the production of hsa_circRNA_025016 may reflect the expression of different sp…”
BackgroundInfluentialUziębło-Życzkowska, B., Gielerak, G., Siedlecki, P., & Pająk, B. (2014) · BioMed Research International · doi:10.1155/2014/462609 · Cited by 9
A short story of the short QT syndrome
Al-Maluli, H., & Meshkov, A. (2013) · Cleveland Clinic journal of medicine · doi:10.3949/ccjm.80a.12029 · Cited by 9
“26,27 Short QT syndromes 4 and 5 were identified by Antzelevitch et al, 28 who described several patients who had a combination of channel abnormalities and ECG findings.”
Genetic Testing of Inherited Arrhythmias
Napolitano, C. (2012) · Pediatric Cardiology · doi:10.1007/s00246-012-0287-7 · Cited by 7
“also reported in a few BrS patients also presenting with short QTc (\360 ms) [1].”
Foyaca-Sibat, H. (2011) · InTech eBooks · doi:10.5772/1137 · Cited by 16
Genetic predisposition to sudden cardiac death
Crotti, L. (2011) · Current Opinion in Cardiology · doi:10.1097/hco.0b013e32834138dd · Cited by 9
When is genetic testing useful in patients suspected to have inherited cardiac arrhythmias?
Fowler, S. J., Napolitano, C., & Priori, S. G. (2009) · Current Opinion in Cardiology · doi:10.1097/hco.0b013e3283335901 · Cited by 11
Chinushi, M., Iijima, K., Tagawa, M., Komura, S., Furushima, H., & Aizawa, Y. (2009) · Journal of Electrocardiology · doi:10.1016/j.jelectrocard.2009.03.009 · Cited by 9
“Third, a recent study has reported that loss-of-function mutations in the cardiac Ca channel were associated with the clinical characteristics of BS.(13) Therefore, the effects of Ca channel blockade on ST-segment elevation may vary among patients, depending on the genetic determinants of the syndrome.”
BackgroundInfluentialSelf-citationPugsley, M., & Curtis, M. (2007) · Journal of pharmacological and toxicological methods · doi:10.1016/j.vascn.2007.05.003 · Cited by 9
Brugada syndrome: Lots of questions, some answers
Roden, D. M. (2009) · Heart Rhythm · doi:10.1016/j.hrthm.2009.10.016 · Cited by 8
Cardiac K+ Channels and Channelopathies.
Schreiber, J., & Seebohm, G. (2021) · Handbook of Experimental Pharmacology · doi:10.1007/164_2021_513 · Cited by 8
Pinsach-Abuin, M., del Olmo, B., Pérez-Agustín, A., Matés, J., Allegue, C., Iglesias, A., Ma, Q., Merkurjev, D., Konovalov, S., Zhang, J., et al. (2021) · Cell Reports Medicine · doi:10.1016/j.xcrm.2021.100250 · Cited by 8
Nakajima, T., Tamura, S., Kurabayashi, M., & Kaneko, Y. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22083930 · Cited by 10
“CACNA1C LQTS (ICa↑) [62,63], SQTS (ICa↓) [80], BrS (ICa↓) [80], ERS (ICa↓) [82]/TS (ICa↑) [23,64,69], ASD (ICa↓) [83,84] KCNJ8 BrS (IK-ATP↑) [95], ERS (IK-ATP↑) [95], AF (IK-ATP↑) [33]”
BackgroundResultInfluentialRole of Non-Coding Variants in Brugada Syndrome
Pérez-Agustín, A., Pinsach‐Abuin, M., & Pagans, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228556 · Cited by 9
Graziano, C., Despang, P., Palombo, F., Severi, G., Posar, A., Cassio, A., Pippucci, T., Isidori, F., Matthes, J., & Bonora, E. (2019) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-020-04551-y · Cited by 8
LRP5 controls cardiac QT interval by modulating the metabolic homeostasis of L-type calcium channel.
Liang, D.-D., Wu, Y.-H., Zhou, L., Chen, Y.-L., Liu, H.-Y., Xie, D., Huang, J., Zhang, Y., Liu, Y., Zhu, W., et al. (2019) · International Journal of Cardiology · doi:10.1016/j.ijcard.2018.06.029 · Cited by 8
Self-citationNovel heterozygous mutation c.4282G>T in the SCN5A gene in a family with Brugada syndrome.
Zhu, J.-F., Du, L.-L., Tian, Y., Du, Y.-M., Zhang, L., Zhou, T., & Tian, L. (2015) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2015.2361 · Cited by 8
Class IV Antiarrhythmic Agents: New Compounds Using an Old Strategy
Szentandrássy, N., Nagy, D., Hegyi, B., Magyar, J., Bányász, T., & Nánási, P. P. (2014) · Current Pharmaceutical Design · doi:10.2174/1381612820666141029105910 · Cited by 11
“CCAs should also be avoided in the treatment of short QT syndrome as in some genetic, congenital forms of the disease (SQT4 and 5) the calcium channels are already conduct a smaller current [140], [141].”
BackgroundA 4.5 Mb terminal deletion of chromosome 12p helps further define a psychosis-associated locus.
Vargas, H., Beldia, G., Korosh, W., Sudhalter, V., Iqbal, A., Sanchez-Lacay, J., & Velinov, M. (2012) · European Journal of Medical Genetics · doi:10.1016/j.ejmg.2012.04.012 · Cited by 8
Recent Developments in the Management of Patients at Risk for Sudden Cardiac Death
Martin, C. A., Huang, C., & Matthews, G. D. K. (2011) · Postgraduate medicine · doi:10.3810/pgm.2011.03.2266 · Cited by 8
Arrhythmia Pharmacogenomics: Methodological Considerations
Roden, D. M., Kannankeril, P. J., & Darbar, D. (2009) · Current Pharmaceutical Design · doi:10.2174/138161209789649529 · Cited by 11
Genetic testing in the management of inherited arrhythmia syndromes
Tzou, W. S., & Gerstenfeld, E. (2009) · Current Cardiology Reports · doi:10.1007/s11886-009-0048-2 · Cited by 8
Ohkubo, K., Watanabe, I., Okumura, Y., Ashino, S., Kofune, M., Ohta, M., Nakai, T., Kunimoto, S., Kasamaki, Y., & Hirayama, A. (2009) · International Heart Journal · doi:10.1536/ihj.50.477 · Cited by 8
Harnessing the Flow of Excitation
Frolov, R. V., & Weckström, M. (2015) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2015.11.001 · Cited by 12
Brugada, P., Brugada, R., Campuzano, Ó., Sarquella‐Brugada, G., Brugada, P., Brugada, V., & Brugada, J. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4557-2856-5.00092-3 · Cited by 7
Clarifying the arrhythmogenic substrate for Brugada syndrome.
Kofune, M., Watanabe, I., Ohkubo, K., Ashino, S., Okumura, Y., Nagashima, K., Mano, H., Nakai, T., Kasamaki, Y., & Hirayama, A. (2011) · International Heart Journal · doi:10.1536/ihj.52.290 · Cited by 8
The Uncommon Phenomenon of Short QT Syndrome: A Scoping Review of the Literature
Boulmpou, A., Giannopoulos, A., Papadopoulos, C., Giannopoulos, G., Papagiannis, I., Zormpas, G., Keivanidou, A., Fidani, L., & Vassilikos, V. (2025) · Journal of Personalized Medicine · doi:10.3390/jpm15030105 · Cited by 7
“…, and KCNQ1 (ClinGen-approved); weaker evidence of mutation in other genes (e.g., CACNA1C , CACNB2 , CACNA2D1 ) [3,4,55,62,77,100,115,121,122,136,137] Associated conditions SQTS often coexists with cardiomyopathies, early repolarization syndrome, and other inherited arrhythmias…”
Overexpression of ATP5F1A in Cardiomyocytes Promotes Cardiac Reverse Remodeling
Xu, M., Zhang, H., Chang, Y., Hua, X., Chen, X., Sheng, Y., Shan, D., Bao, M., Hu, S., & Song, J. (2024) · Circulation Heart Failure · doi:10.1161/circheartfailure.123.011504 · Cited by 6
Brugada syndrome: a fatal disease with complex genetic etiologies – still a long way to go
Wu, Y.-D., Ai, M., Bardeesi, A., Xu, L., Zheng, J.-J., Zheng, D., Yin, K., Wu, Q., Zhang, L., Huang, L., et al. (2017) · Forensic Sciences Research · doi:10.1080/20961790.2017.1333203 · Cited by 7
“[77] found a heterozygous C1442T transition in exon 13, causing a substitution of leucine for serine at position 481 (S481L) of CACNB2b, in one”
BackgroundSelf-citationAvoiding sports-related sudden cardiac death in children with congenital channelopathy
Lang, C. N., Steinfurt, J., & Odening, K. (2017) · Herz · doi:10.1007/s00059-017-4549-2 · Cited by 7
“Physiological exercise-induced QT shortening is less pronounced in SQTS patients than in the healthy population [25, 72, 75], which may predispose to arrhythmia.”
BackgroundEden, M., Meder, B., Völkers, M., Poomvanicha, M., Domes, K., Branchereau, M., Marck, P., Will, R., Bernt, A., Rangrez, A., et al. (2016) · Nature Communications · doi:10.1038/ncomms11835 · Cited by 7
Atrial arrhythmias in inherited arrhythmogenic disorders
Hasdemir, C. (2016) · Journal of Arrhythmia · doi:10.1016/j.joa.2015.11.007 · Cited by 7
β‐Blockers in Congenital Short‐QT Syndrome as Ion Channel Blockers
Abriel, H., & Rougier, J. (2013) · Cardiovascular Electrophysiology · doi:10.1111/jce.12204 · Cited by 7
Genetic biomarkers in Brugada syndrome.
Li, A. C., Saba, M. M., & Behr, E. (2013) · Biomarkers in Medicine · doi:10.2217/bmm.13.78 · Cited by 7
Evidence for a vast peptide overlap between West Nile virus and human proteomes
Capone, G., Pagoni, M., Delfino, A., & Kanduc, D. (2012) · Journal of Basic Microbiology · doi:10.1002/jobm.201200204 · Cited by 7
“When this situation occurs (called ventricular fibrillation), the individual will faint and may die in a few minutes if the heart is not reset [38].”
BackgroundSudden Cause of Cardiac Death—Be Aware of Me: A Case Report and Short Review on Brugada Syndrome
Kalavakunta, J., Bantu, V., Tokala, H., & Kodenchery, M. (2010) · Case Reports in Medicine · doi:10.1155/2010/823490 · Cited by 7
Hypercalcaemia and a Brugada-like ECG: An independent risk factor for fatal arrhythmias.
Zeb, M., Mckenzie, D., Naheed, B., Gazis, T., Morgan, J., & Staniforth, A. (2010) · Resuscitation · doi:10.1016/j.resuscitation.2010.04.025 · Cited by 7
Mitochondrial Component of Calcium Signaling Abnormality in Autism
Gargus, J. J. (2009) · CRC Press eBooks · doi:10.1201/9781420068870-c11 · Cited by 6
Efremidis, M., Letsas, K., Weber, R., Gavrielatos, G., Filippatos, G., Sideris, A., & Kardaras, F. (2009) · Clinical Research in Cardiology · doi:10.1007/s00392-009-0083-4 · Cited by 7
“Quinidine has been shown to normalize the QT interval in subjects with BS and short QT intervals carrying CACNA1C or CACNB2 gene mutations as well in subjects with SQTS carrying a KCNH2 gene mutation [2, 6].”
BackgroundGenetic basis of Brugada syndrome.
Antzelevitch, C. (2007) · Heart Rhythm · doi:10.1016/j.hrthm.2007.03.015 · Cited by 7
Self-citationCrotti, L., Kotta, M., & Castelletti, S. (2018) · Cardiac and vascular biology · doi:10.1007/978-3-319-77812-9_7
Brugada Syndrome: Cellular Mechanisms and Approaches to Therapy
Antzelevitch, C., & Viskin, S. (2008) · Springer eBooks · doi:10.1007/978-1-4471-4881-4_29 · Cited by 7
Self-citationMorfin, P. J. D. R., Chavez, D. S., Jayaraman, S., Yang, L., Geisler, S. M., Kochiss, A. L., Tuluc, P., Colecraft, H. M., Marx, S. O., Liu, X. S., et al. (2024) · Science Advances · doi:10.1126/sciadv.adq3374 · Cited by 6
“From a pathophysiological perspective, gain- of-function Ca V 1.2 variants are linked to a multisystem disorder, Timothy syndrome ( 16 ), while loss- of-function variants are associated with cardiac arrhythmias ( 17 , 18 ) and variable neurological phenotypes ( 17 , 19 ).”
InfluentialPesaresi, M., Michele, A. B. D., Melchionda, F., Onofri, V., Alessandrini, F., & Turchi, C. (2024) · Genes · doi:10.3390/genes15101272 · Cited by 6
“…(SQTS) is a rare, sporadic or autosomal dominant channelopathy characterized by a constantly short QT interval and accelerated cardiac repolarization manifested by atrial fibrillation, syncopal episodes and/or sudden cardiac death in patients with no underlying structural heart disease [36].”
BackgroundCongenial short QT syndrome: A review focused on electrocardiographic features.
Pérez-Riera, A. R., Barbosa-Barros, R., Rocha, M. D. S., Paixão-Almeida, A., Daminello-Raimundo, R., de Abreu, L. C., Yanowitz, F. D., Baranchuk, A., & Nikus, K. C. (2024) · Journal of Electrocardiology · doi:10.1016/j.jelectrocard.2024.04.009 · Cited by 6
Despang, P., Salamon, S., Breitenkamp, A. F., Kuzmenkina, E. V., & Matthes, J. (2022) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-022-02213-7 · Cited by 7
Tambi, R., Hameid, R. A., Bankapur, A., Nassir, N., Begum, G., Alsheikh-Ali, A. A. A., Uddin, M. J., & Berdiev, B. K. (2021) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00061.2021 · Cited by 7
Learning from studying very rare cardiac conditions: the example of short QT syndrome
Hancox, J., Whittaker, D. G., Zhang, H.-G., & Stuart, A. G. (2019) · Journal of Congenital Cardiology · doi:10.1186/s40949-019-0024-7 · Cited by 6
Ventricular and Supraventricular Ectopy in Subjects With Early Repolarization.
Trenkwalder, T., King, R., Kaess, B., Hengstenberg, C., Schunkert, H., Ittermann, T., Felix, S., Busch, M. C., Dörr, M., & Reinhard, W. (2017) · American Journal of Cardiology · doi:10.1016/j.amjcard.2017.03.254 · Cited by 6
Polymorphic ventricular tachycardia--part II: the channelopathies.
Choudhuri, I., Pinninti, M., Marwali, M., Sra, J., & Akhtar, M. (2013) · Current problems in cardiology · doi:10.1016/j.cpcardiol.2013.07.004 · Cited by 6
Role of Genetic Testing for Sudden Death Predisposing Heart Conditions in Athletes
Landstrom, A. P., Tester, D. J., & Ackerman, M. J. (2010) · Springer eBooks · doi:10.1007/978-0-387-92775-6_5 · Cited by 6
“Recently, mutations involving the L-type calcium channel a (CACNA1C) and b (CACNB2B) subunits have been implicated in nearly 10% of BrS cases [ 38 ] while mutations in the putative b-subunit of the transient outward potassium channel (Ito, KCNE3) have been reported as a rare cause [39].”
BackgroundPathophysiology of atrial fibrillation
Jalife, J., Allessie, M. A., Antzelevitch, C. N., Iesaka, Y., Jackman, W. M., Scheinman, M. M., & Chen, S. (2011) · Wiley eBooks · doi:10.1002/9781119963868.ch2 · Cited by 86
Molecular Investigations of Sudden Unexplained Deaths
Tang, Y., Siegel, D. S., & Sampson, B. A. (2011) · Academic Forensic Pathology · doi:10.23907/2011.025 · Cited by 9
Genetics Primer for the General Cardiologist
MacRae, C. A. (2011) · Circulation · doi:10.1161/circulationaha.111.018879 · Cited by 5
How the heart can fibrillate: when diversity is a disadvantage.
Lazzara, R. (2010) · Heart Rhythm · doi:10.1016/j.hrthm.2009.10.033 · Cited by 6
Risk Stratification in Electrical Cardiomyopathies
Veltmann, C., Schimpf, R., Borggrefe, M., & Wolpert, C. (2009) · Herz Kardiovaskuläre Erkrankungen · doi:10.1007/s00059-009-3288-4 · Cited by 6
“Mutations in six different genes are described causing the clinical and electrocardiographic phenotype of Brugada syndrome [34, 53–56].”
BackgroundSelf-citationRiera, A. P., Filho, C. F., Uchida, A., Zhang, L., Antzelevitch, C., Schapachnik, E., Dubner, S., & Ferreira, C. (2008) · Annals of Noninvasive Electrocardiology · doi:10.1111/j.1542-474x.2008.00248.x · Cited by 6
Self-citationThe year in arrhythmias 2007: Part II
Josephson, M. E., Rosen, M. R., & Tomaselli, G. F. (2008) · Heart Rhythm · doi:10.1016/j.hrthm.2008.03.013
The Molecular Pathophysiology of Atrial Fibrillation
Nattel, S., Heijman, J., Voigt, N., Wehrens, X. H. T., & Dobrev, D. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-44733-1.00042-0 · Cited by 6
Mechanism and new findings in Brugada syndrome.
Shimizu, W., Aiba, T., & Kamakura, S. (2007) · Circulation Journal · doi:10.1253/circj.71.a32 · Cited by 6
Disorders of Cardiac Repolarization
Horie, M., & Itoh, H. (2007) · Circulation Journal · doi:10.1253/circj.71.a50 · Cited by 6
Underwood, J. F. G., Timothy, K. W., Tyroll, H., Levy, R. J., Dick, I. E., Pitt, G. S., Tunbridge, E., Baban, A., Wilkinson, G., Hall, N., et al. (2025) · Research Square · doi:10.21203/rs.3.rs-8058536/v1 · Cited by 5
“For BrS and SQTS studies provide only limited support for a link between CACNA1C and those phenotypes, and the causal relationship is disputed (11), as further evidenced by ClinGen’s re-evaluation of the literature (12).”
InfluentialARumenamides: A novel class of potential antiarrhythmic compounds
Abdelsayed, M., Page, D. A., & Ruben, P. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.976903 · Cited by 5
A descriptive report on short QT interval in Kherameh branch of the PERSIAN cohort study
Nikoo, M., Heiran, A., Mashayekh, F., Rezaianzadeh, A., Shiravani, A., & Azadian, F. (2022) · Scientific Reports · doi:10.1038/s41598-022-06835-y · Cited by 5
Genetics in cardiovascular diseases
Celeghin, R., Thiene, G., Bauce, B., Basso, C., & Pilichou, K. (2019) · Italian Journal of Medicine · doi:10.4081/itjm.2019.1186 · Cited by 6
Matusik, P., Pudło, J., Rydlewska, A., Podolec, J., Lelakowski, J., & Podolec, P. (2017) · doi:10.20418/jrcd.vol3no3.291 · Cited by 5
Pathophysiology of Idiopathic Atrial Fibrillation - Prognostic and Treatment Implications
Weijs, B., Schotten, U., & Crijns, H. J. G. M. (2014) · Current Pharmaceutical Design · doi:10.2174/1381612820666140825150057 · Cited by 7
“[124] CACNA1c/B2 ICaL 12p13.”
Herring, M. J., Hale, S., Shi, J.-R., Oskui, P. M., Kay, G. L., & Kloner, R. (2014) · Cardiovascular Pharmacology Open Access · doi:10.4172/2329-6607.1000115 · Cited by 5
Risk Stratification and Therapeutic Approach in Brugada Syndrome.
Probst, V., Chatel, S., Gourraud, J., & Marec, H. L. (2012) · Arrhythmia & Electrophysiology Review · doi:10.15420/aer.2012.1.1.17 · Cited by 5
“From two families, mutations in the SCN1B gene were identified leading to a decrease of sodium current and inducing conduction disturbances and an aspect of BrS in some patients.40 More recently, a mutation in MOG1 gene, partner of Nav 1.5, was identified.41 Several gain of function mutations have been described in ge…”
BackgroundInfluentialCoexisting vasospastic angina and undiagnosed Brugada syndrome resulting in cardiac arrest.
Chow, V., Ranasinghe, I., & Yiannikas, J. (2011) · International Journal of Cardiology · doi:10.1016/j.ijcard.2009.11.012 · Cited by 5
Molecular genetics of Brugada syndrome
Ke, T., Tu, X., Zhang, S.-Y., Liao, Y.-H., & Wang, Q. (2010) · Frontiers in Biology · doi:10.1007/s11515-010-0056-z · Cited by 5
“In addition, the “ mixed ” electro-cardiographic patterns including phenotypic overlap with long QT syndrome, short QT syndrome, or cardiac conduction disease have been reported (Bezzina et al., 1999; Shirai et al., 2002; Antzelevitch et al., 2007).”
Genetic testing for channelopathies, more than ten years progress and remaining challenges
Zhou, P., & Wang, J.-H. (2010) · Journal of Cardiovascular Disease Research · doi:10.4103/0975-3583.64429 · Cited by 5
“2 α-subunit, gives rise to calcium channel “loss-of-function”;[9] CACNB2, encoding the Cav1.”
BackgroundBenito, B., Brugada, J., Brugada, R., & Brugada, P. (2009) · Revista Española de Cardiología · doi:10.1016/s0300-8932(09)73082-9 · Cited by 5
The Genetic Basis of Malignant Arrhythmias and Cardiomyopathies
Campuzano, Ó., Sarquella‐Brugada, G., Brugada, R., Brugada, P., & Brugada, J. (2009) · Revista Española de Cardiología (English Edition) · doi:10.1016/s1885-5857(09)71669-x · Cited by 6
Genetics of Arrhythmia: Disease Pathways Beyond Ion Channels
Perez, M. V., Wheeler, M. T., Ho, M. Y., Pavlović, A., Wang, P. J., & Ashley, E. A. (2008) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-008-9030-4 · Cited by 5
Briot, J., Tétreault, M.-P., Bourdin, B., & Parent, L. (2017) · Advances in experimental medicine and biology · doi:10.1007/5584_2016_186 · Cited by 8
Refaat, M., Hotait, M., & Scheinman, M. (2016) · Cardiac Electrophysiology Clinics · doi:10.1016/j.ccep.2015.10.036 · Cited by 5
“mutations in CACNB2b showed channel trafficking impairment.(16) CACNAD1 is another gene encoding a2d subunit of this channel.”
BackgroundIdentifying risk of cardiac events in short QT syndrome.
Kobza, R. (2012) · Heart Rhythm · doi:10.1016/j.hrthm.2011.09.002 · Cited by 5
Local calcium dynamics and signalling in cardiomyocytes
Bénitah, J., Pereira, L., Perrier, R., Mercadier, J., Sabourin, J., & Gómez, A. (2026) · Nature Reviews Cardiology · doi:10.1038/s41569-026-01286-8 · Cited by 4
“Genetic variants in CACNB2 are linked to sudden cardiac death and arrhythmic syndromes 46,47 .”
Botti, S., Krause, R., & Pavarino, L. (2025) · Journal of Physiology · doi:10.1113/jp287276 · Cited by 4
“Loss-of-function mutations in these genes impair LTCC expression, trafficking or function, leading to reduced Ca 2 + current (Antzelevitch et al., 2007).”
Sarquella-Brugada, G., Martínez-Barrios, E., César, S., Toro, R., Cruzalegui, J., Greco, A., Díez-Escuté, N., Cerralbo, P., Chipa, F., Arbelo, E., et al. (2024) · BMJ Open Sport & Exercise Medicine · doi:10.1136/bmjsem-2023-001852 · Cited by 4
“These especial situations not classified as a definite SQTS. Syncope and SCD often occur during periods of rest or sleep but arrhythmias in exercise situations have been also reported.”
BackgroundInfluentialDow, R., DeLong, C. J., Jiang, G., Attili, D., Creech, J., Kraan, R., Campbell, K., Saraithong, P., O'Shea, S. K., da Rocha, A. L. M., et al. (2024) · Biological Psychiatry Global Open Science · doi:10.1016/j.bpsgos.2024.100296 · Cited by 4
Zeng, B., Zhang, X., Schimpf, R., Powers, A., Glikson, M., Antzelevitch, C., Hu, D., & Barajas-Martinez, H. (2023) · Philosophical Transactions of the Royal Society of London. Biological Sciences · doi:10.1098/rstb.2022.0286 · Cited by 4
Self-citationParthiban, N., & Sani, H. (2023) · European Heart Journal: Case Reports · doi:10.1093/ehjcr/ytad196 · Cited by 4
“Although the genetic mutation is not part of the diagnostic criteria for Brugada syndrome, numerous studies have demonstrated the association between the loss of function mutation of the cardiac L-type calcium channel and the Brugada syndrome phenotype.(12,13,14) In recent years, the arrhythmogenic potential of MVP ca…”
BackgroundBrugada syndrome: current concepts and genetic background
Pérez-Riera, A. R., Mendes, J. E. T., da Silva, F. N. F., Yanowitz, F., de Abreu, L. C., Figueiredo, J. L., Raimundo, R. D., Barbosa-Barros, R., Nikus, K., & Brugada, P. (2021) · Journal of Human Growth and Development · doi:10.36311/jhgd.v31.11074 · Cited by 4
Hasdemir, C., Gokcay, F., Orman, M., Kocabaş, U., Payzın, S., Şahin, H., Nyholt, D., & Antzelevitch, C. (2020) · Cardiovascular Electrophysiology · doi:10.1111/jce.14778 · Cited by 4
Self-citationGoit, L. N., & Yang, S.-N. (2019) · Yangtze Medicine · doi:10.4236/ym.2019.34023 · Cited by 4
“These genes only account for small percentage of Brugada syndrome [14].”
BackgroundBartels, P., Yu, D.-J., Huang, H., Hu, Z., Herzig, S., & Soong, T. (2018) · Biophysical Journal · doi:10.1016/j.bpj.2018.06.001 · Cited by 4
“2 loss of function resulting in ventricular arrhythmia (56).”
BackgroundResultNagamoto, Y., Fujii, Y., Morita, Y., Ueda, Y., Yamane, K., Miyake, Y., Fujiwara, M., Mito, S., Watari, Y., Tamekiyo, H., et al. (2017) · doi:10.1016/j.ihjccr.2017.12.003 · Cited by 4
Brugada Syndrome: Evolving Insights and Emerging Treatment Strategies
Duffett, S., & Roberts, J. D. (2017) · Journal of Innovations in Cardiac Rhythm Management · doi:10.19102/icrm.2017.080205 · Cited by 4
Li, K. H. C., Liu, T., To, O., Chan, Y., Tse, G., & Yan, B. P. (2016) · doi:10.5812/cardiovascmed.42085 · Cited by 4
Watanabe, H., & Minamino, T. (2013) · Journal of Arrhythmia · doi:10.1016/j.joa.2013.01.007 · Cited by 4
“The QT interval is unusually short in patients with Brugada syndrome who are affected by specific genetic defects (mutations in calcium channel genes), as described below [24].”
BackgroundSíndrome de Brugada: puesta al día
Heras, R. P. (2013) · Cardiocore · doi:10.1016/j.carcor.2012.10.001 · Cited by 4
Wolpert, C., Veltmann, C., Schimpf, R., Borggrefe, M., Herrera-Siklódy, C., Parade, U., Strotmann, C., & Rüb, N. (2012) · Herzschrittmachertherapie & Elektrophysiologie · doi:10.1007/s00399-012-0229-3 · Cited by 4
Self-citation
Metadata
- Authors
- Antzelevitch, C., Pollevick, G. D., Cordeiro, J. M., Casis, O., Sanguinetti, M. C., Aizawa, Y., Guerchicoff, A., Pfeiffer, R., Oliva, A., Wollnik, B., Gelber, P., Bonaros, E. P., Burashnikov, E., Wu, Y., Sargent, J. D., Schickel, S., Oberheiden, R., Bhatia, A., Hsu, L.-F., Haïssaguerre, M., Schimpf, R., Borggrefe, M., & Wolpert, C.
- Affiliations
- University of Cologne (DE)
- From the Masonic Medical Research Laboratory (C.A., G.D.P., J.M.C., H.A., A.G., R.P., A.O., E.B., Y.W.), Utica, NY; Nora Eccles Harrison Cardiovascular Research and Training Institute (O.C., M.C.S., J.D.S.), University of Utah, Salt Lake City, Utah; Center for Molecular Medicine Cologne (B.W.), Institute of Human Genetics, University of Cologne, Germany; Cardiovascular Consultants of Long Island (P.G., E.P.B.), New Hyde Park, NY; Department of Internal Medicine (S.S., R.O.), Academic Hospital...
- ORCID
- Venue
- Circulation
- Published
- 2007-01-30
- Volume
- 115
- Issue
- 4
- Pages
- 442-449
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- PMC
- PMC1952683
- OpenAlex
- W2089861793
- Cited by
- 933
- References
- 0
- Citations by year
- 2026: 9 · 2025: 17 · 2024: 22 · 2023: 24 · 2022: 25 · 2021: 35 · 2020: 34 · 2019: 35 · 2018: 47 · 2017: 60 · 2016: 55 · 2015: 51 · 2014: 44 · 2013: 85 · 2012: 82
- FWCI
- 54.48
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Circulation (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- GRO (submittedVersion)
- Funders
- National Heart, Lung, and Blood Institute (R01HL047678)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ion channel regulation and function
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Effects of Exercise
- Keywords
- Brugada syndrome, L-type calcium channels, CACNA1C, CACNB2, CACNA2D1, loss-of-function mutations, sudden cardiac death, short QT interval, ST-segment elevation, cardiac ion channelopathy, channel trafficking, quinidine, ventricular tachycardia, familial arrhythmia
- MeSH terms
- Adult, Animals, Cricetulus, Electrocardiography, Family Health, Female, Cricetinae, Humans, Genetic Linkage, Male, Phenotype, Registries, Ventricular Fibrillation, Calcium Channels, Mutagenesis, Site-Directed, CHO Cells, Death, Sudden, Cardiac, Tachycardia, Ventricular, Patch-Clamp Techniques, Mutation, Missense, Calcium Channels, L-Type, White People
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review